July 26, 2017
HCA Midwest Health, Kansas City’s leading healthcare and premier provider of cardiovascular services, announces that Dr. Stephen A. Bloom, M.D., has been elected by his peers to serve on the American Society of Nuclear Cardiology Board of Directors. The Board serves a critical role in advancing the field of nuclear cardiology, which plays an integral role in the diagnosis and treatment of heart disease. Bloom is affiliated with Centerpoint Medical Center, Menorah Medical Center, Overland Park Regional Medical Center and Research Medical Center and is the director of the Clinical Research Department for Midwest Heart & Vascular Specialists in Overland Park.
“Dr. Bloom is a well-respected nuclear cardiologist in the Kansas City region,” says Dr. Steven Marso, M.D., an interventional cardiologist and Medical Director of Cardiovascular Services at HCA Midwest Health. “His contribution to the American Society of Nuclear Cardiology Board of Directors will help ensure that nuclear cardiology studies will continue to play an important role in the noninvasive diagnosis of coronary artery disease, the assessment of the pumping function of the heart and in the prediction of outcomes in patients with heart disease.”
“I am humbled to receive this nod from my colleagues and join the American Society of Nuclear Cardiology Board of Directors,” says Bloom. “I have been a member since its inception in 1994 and know firsthand the important work that is done for continuous quality improvement, education and patient-centered imaging and improving patient outcomes. To be able to contribute to the field of nuclear cardiology in this way is an honor and a tribute to the work I am able to do every day with my patients in the Kansas City area.”
Bloom earned his bachelor's degree from Clark University, graduating magna cum laude, and earned his medical degree from the University of Connecticut School of Medicine. He completed his residency in internal medicine and his fellowship in cardiology at Tufts University School of Medicine and St. Elizabeth's Hospital of Boston. Board-certified in internal medicine, cardiovascular diseases, nuclear cardiology and cardiovascular computed tomography, Bloom has expertise cardiovascular imaging techniques, including nuclear cardiology, echocardiography, coronary angiography and multi-slice computed tomography. Bloom is the lead investigator of numerous clinical trials and a fellow of the American College of Cardiology, a Gold Heart member of the American Heart Association, a fellow of American Society of Nuclear Cardiology and a founding member and fellow of the Society of Cardiovascular Computed Tomography.
The leading cause of death in the U.S., heart disease, or coronary artery disease, results from narrowing, or constriction, of the blood vessels that supply blood to the heart. The blood vessels become narrow when fatty deposits build up inside the arterial wall. As the arteries become clogged, and diseased, the blood flow to the heart muscle is impaired and a heart attack can occur. Nuclear imaging studies use noninvasive techniques to assess blood flow, evaluate the pumping function of the heart, as well as, pinpoint the blockage area. Once a blockage is identified by these noninvasive studies
medical intervention can be used to treat the patient, with precision and accuracy from reading the nuclear imaging results. Therefore, physicians can identify patients at risk before a cardiac event occurs.
For more information on HCA Midwest Health and its heart care program, cardiovascular services and experts, visit http://hcamidwest.com/service/heart-care.